Attend the next MICCAI Industrial Talk - May 3, 2024

Thursday 18th April 2024

Join us for the next exciting talk in our MICCAI Industrial Talk Series.

Leveraging Data Science & AI to Create Transformational Medicines

Date/Time: May 3, 2024 10:00 AM (EST) / 3:00 PM (GMT)
(Attendance is free. Please register in advance usingĀ this link)

Abstract: Artificial intelligence (AI) is transforming the field of drug discovery and development, enabling novel approaches to help accelerate the development of transformational medicines. This talk will present examples of applications of AI, spanning from the molecular to the clinical level, and discuss their potential impact and limitations.

Specific areas of focus will include:

  • how deep learning and computer vision can be used to analyze large-scale cellular images, identify disease phenotypes and discover novel drug targets
  • how generative AI models can be used to help co-design novel proteins and molecules with desired properties and functions
  • how medical imaging applications for clinical trials, for instance for the development of novel endpoints or the predictions of disease progression and therapy outcome.

The talk will conclude by highlighting some of the current challenges and future directions for AI in drug discovery and development.

About the presenter

Dr. Tommaso Mansi is VP of Artificial Intelligence (AI) and Digital Health, Data Science, at Janssen R&D. He holds a PhD in biomedical engineering from INRIA Sophia Antipolis, France. Afterward graduating, Dr. Mansi worked at Siemens Healthineers, Digital Technology and Innovation, where he took roles of increasing responsibility and eventually led a team focusing on the development and translation of AI solutions for image-guided therapy and robotics. He then joined Janssen R&D, Data Science, in 2021. In his current position, Dr. Mansi focuses on the research and development of AI approaches spanning digital health, computer vision, and biology, to derive advanced insights from multimodal, biomedical data and accelerate drug discovery and development. Throughout his career, Dr. Mansi and the teams he worked with received several awards and gave multiple keynotes at international conferences. He holds 70+ granted US patents, co-edited 1 monograph and co-authored 100+ scientific publications.